Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...

Bristol-Myers Squibb has formed an R&D partnership with GentiBio, aimed at developing regulatory T cel (Treg) therapies for inflammatory bowel disease (IBD). The deal includes an undisclosed upfront ...

Bristol Myers Squibb has moved to take full control of the CAR-T therapy it partners with 2seventy bio, agreeing to buy the biotech for around $286 million. The $5.00-per-share offer – announced at ...

Bristol Myers Squibb has ended the week with an agreement to buy Orbital Therapeutics – a developer of in vivo cell therapies – for $1.5 billion in cash. Cambridge, Massachusetts-based Orbital is ...

Bristol-Myers Squibb has upgraded a long-running alliance with Prothena in Alzheimer’s disease, taking an option on a tau protein-targeting antibody in early-stage clinical development. The deal – ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Abigail Bailey Abigail Bailey is a writer on the kitchen team. Her subjects ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› by Gabriella DePinho They have one job, and they get it done! From our favorite ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Tim Heffernan Tim Heffernan covers air and water filtration, as well as ...

Copyright © 2026 BBC. The BBC is not responsible for the content of external sites. Read about our approach to external linking.

Here’s a recipe you can make quickly that will fill you and your family up with tasty protein. Makes 12 sliders.